0001209191-14-033826.txt : 20140514 0001209191-14-033826.hdr.sgml : 20140514 20140514180556 ACCESSION NUMBER: 0001209191-14-033826 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140512 FILED AS OF DATE: 20140514 DATE AS OF CHANGE: 20140514 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUESTCOR PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000891288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330476164 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1300 NORTH KELLOGG DRIVE STREET 2: SUITE D CITY: ANAHEIM STATE: CA ZIP: 92807 BUSINESS PHONE: 714-786-4200 MAIL ADDRESS: STREET 1: 1300 NORTH KELLOGG DRIVE STREET 2: SUITE D CITY: ANAHEIM STATE: CA ZIP: 92807 FORMER COMPANY: FORMER CONFORMED NAME: CYPROS PHARMACEUTICAL CORP DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mulroy Michael H. CENTRAL INDEX KEY: 0001509725 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14758 FILM NUMBER: 14842943 MAIL ADDRESS: STREET 1: 1300 N. KELLOGG DRIVE, SUITE D CITY: ANAHEIM STATE: CA ZIP: 92807 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-05-12 0 0000891288 QUESTCOR PHARMACEUTICALS INC QCOR 0001509725 Mulroy Michael H. 1300 NORTH KELLOGG DRIVE SUITE D ANAHEIM CA 92807 0 1 0 0 See Remarks Common Stock 2014-05-12 4 M 0 10000 14.24 A 87063 D Common Stock 2014-05-12 4 S 0 5000 88.0103 D 82063 D Common Stock 2014-05-12 4 S 0 5000 87.9713 D 77063 D Stock Option (right to buy) 14.24 2014-04-10 4 M 0 10000 0.00 D 2021-02-15 Common Stock 10000 95000 D Stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan. The option was granted on 02/16/2011 for the right to buy 125,000 shares of common stock of the Issuer. The option provided for monthly vesting over 48 months from the date of grant, with a 12-month cliff, whereby no options vested until after the twelfth month from the date of the grant. The prices reported in Column 4 are weighted average prices. These shares were sold in multiple transactions at prices ranging from $87.15-88.32 and 87.26-88.32, respectively. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Title: EVP, Strategic Affairs and General Counsel The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan (the "Automatic Trading Plan") adopted by the reporting person in the second quarter of 2013 and effective 90 days post-adoption. There have been no changes to the Automatic Trading Plan since its adoption. The first sale under the Automatic Trading Plan occurred on March 10, 2014, and there have been no sales by the Reporting Person outside of the Automatic Trading Plan since its adoption. The Automatic Trading Plan controls the exact dates and amounts of sales. /s/ Michael H. Mulroy 2014-05-14